Switching from originator infliximab to biosimilar CT-P13 in real-life: The weight of patient acceptance
Keywords: اسپوندیلیت انکیلوزان; Rheumatoid arthritis; Ankylosing spondylitis; Spondyloarthropathies; Patient attitude to health; Anti-TNF-alpha; DMARDs (biologics);